Walleye Capital’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Walleye Capital’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-65,774	Closed	-$686K	–	5132
2023 Q1	$686K	Hold	65,774	–	–	0.01%	1431
2022 Q4	$670K	Hold	65,774	–	–	0.01%	1254
2022 Q3	$660K	Hold	65,774	–	–	0.01%	1260
2022 Q2	$655K	Sell	65,774 -200	-0.3%	-$2K	0.02%	859
2022 Q1	$658K	Buy	+65,974	New	+$655K	0.02%	852

Walleye Capital's LVAC Position: Q2 2023 in Review

Walleye Capital sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 65,774 shares — an estimated $686K sold.

Walleye Capital first reported a position in LVAC in Q1 2022 and held it in 5 quarters. The position peaked at $686K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Walleye Capital reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 65,774 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $686K.
Walleye Capital first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Walleye Capital's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $686K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.